CAPTURE-troponin substudy

CAPTURE—troponin substudy

c7E3 Fab Antiplatelet Therapy in Unstable Refractory angina—troponin substudy. A study that asked if serum troponin T levels identify patients most likely to benefit from abciximab.
Primary endpoints
MI or death at 30 days.
Serum troponin identifies a high-risk subgroup of patients with unstable angina suitable for coronary angioplasty who benefit from antiplatelet treatment with abciximab.